HIV p24

HIV p24 Full Name

Human immunodeficiency virus P24

HIV p24 Introduction

The p24 protein serves as the capsid core protein encoded by the HIV-1 gag gene and represents the most abundantly produced viral protein during infection. As the primary structural component of viral particles, p24 forms the conical core that encapsulates the viral RNA genome and associated enzymes. Its remarkable conservation across diverse HIV-1 variants makes it an invaluable target for diagnostic applications and vaccine development. The protein's structural integrity is essential for proper virion assembly, maturation, and subsequent infectivity. Research has established that p24 can be detected in blood plasma during the earliest stages of infection, often appearing within days of exposure and preceding the development of host antibody responses by several weeks. This characteristic positions p24 as a critical early infection marker, enabling healthcare providers to identify acute HIV infection during the window period when antibody-based tests remain negative. The abundance of p24 in infected cells and virions—far exceeding other viral proteins—amplifies its detectability and reinforces its historical importance as a biomarker for monitoring viral replication dynamics and disease progression.

Figure 1. Structural Diagram of HIV Virion Highlighting p24 Capsid.

The clinical application of p24 antigen detection has revolutionized HIV diagnosis by significantly expanding the detectable window during acute infection. Fourth-generation combination immunoassays represent a major advancement, simultaneously detecting both p24 antigen and anti-HIV antibodies within a single test platform. This dual-target approach has reduced the diagnostic window period by approximately one week compared to antibody-only tests, enabling earlier identification of recently infected individuals. However, p24-based diagnostics face important biological challenges that complicate their utility. During chronic infection, the formation of immune complexes—where p24 binds to anti-p24 antibodies—can sequester free antigen and reduce assay sensitivity. Studies have shown that without intervention, conventional p24 tests may fail to detect antigen in a substantial proportion of chronically infected individuals. To overcome this limitation, researchers have developed immune complex dissociation protocols using acid or chemical treatments that liberate bound p24 for accurate quantification. Furthermore, ultrasensitive detection platforms incorporating digital ELISA technology have pushed detection limits to near nucleic acid test benchmarks, demonstrating strong correlations with viral RNA and DNA measurements across infection stages. These technological innovations have reinvigorated interest in p24 as a complementary tool for treatment monitoring and reservoir studies, although such applications remain primarily investigational in routine clinical practice.

Beyond diagnostics, p24 has emerged as an essential tool for investigating HIV persistence and reservoir biology. Flow cytometry-based detection of p24-positive cells enables researchers to identify and characterize productively infected cells at the single-cell level, providing insights that bulk measurements cannot capture. Studies employing this approach have revealed that p24-positive cells predominantly exhibit memory T-cell phenotypes and express activation markers, correlating with cellular permissiveness to viral replication. Importantly, sorted p24-positive cells demonstrate significant enrichment for HIV DNA, validating p24 as a functional readout of viral protein production and enabling deeper reservoir analysis. In antiretroviral therapy-suppressed individuals, p24-positive cells are rarely detectable without ex vivo stimulation, whereas in untreated infection, their frequencies correlate strongly with plasma viral load—underscoring p24's utility as a direct marker of active viral replication. The development of standardized protocols and reproducible methodologies has positioned p24-based single-cell analysis as a valuable endpoint in cure research, vaccine evaluation, and therapeutic intervention studies. Additionally, p24's structural conservation has informed immunological investigations into CD4+ T cell responses and dendritic cell presentation, contributing to vaccine design strategies. While nucleic acid-based measurements remain the gold standard for clinical viral load monitoring, p24 quantification offers complementary information about viral protein dynamics and cellular infection states. As ultrasensitive detection technologies continue to advance, p24-based approaches hold promise for personalized treatment monitoring, assessment of residual viremia, and evaluation of latency-reversing strategies in the pursuit of HIV cure.

Alternate Names for HIV p24

HIV P24; Human immunodeficiency virus P24

• Humanized Control Antibodies for Infectious Disease Diagnostics
• Humanized Control Antibodies for Infectious Disease Diagnostics

• 1. Bozzacco L., et al. Strategy for Identifying Dendritic Cell-Processed CD4+ T Cell Epitopes from the HIV Gag p24 Protein. Plos One. 2012;7(7):e41897.
  2. Chunduri L., et al. Femtogram Level Sensitivity achieved by Surface Engineered Silica Nanoparticles in the Early Detection of HIV Infection. Scientific Reports. 2017;7(1).
  3. Hess R., et al. Glycosylation of HIV Env Impacts IgG Subtype Responses to Vaccination. Viruses. 2019;11(2):153.